Biogen beats by $0.22, beats on revenue

• Biogen (NASDAQ:BIIB): Q3 EPS of $5.19 beats by $0.22.
• Revenue of $2.96B (+6.5% Y/Y) beats by $50M.
• Shares +1.4% PM.
• Press Release